Growth Metrics

Avadel Pharmaceuticals (AVDL) Gross Margin: 2009-2020

Historic Gross Margin for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2020 value amounting to 74.29%.

  • Avadel Pharmaceuticals' Gross Margin fell 1192.00% to 67.45% in Q2 2020 from the same period last year, while for Jun 2020 it was 76.91%, marking a year-over-year decrease of 395.00%. This contributed to the annual value of 74.29% for FY2020, which is 523.00% down from last year.
  • According to the latest figures from FY2020, Avadel Pharmaceuticals' Gross Margin is 74.29%, which was down 6.58% from 79.52% recorded in FY2019.
  • In the past 5 years, Avadel Pharmaceuticals' Gross Margin registered a high of 91.18% during FY2016, and its lowest value of 74.29% during FY2020.
  • Its 3-year average for Gross Margin is 78.95%, with a median of 79.52% in 2019.
  • Data for Avadel Pharmaceuticals' Gross Margin shows a maximum YoY crashed of 755bps (in 2018) over the last 5 years.
  • Avadel Pharmaceuticals' Gross Margin (Yearly) stood at 91.18% in 2016, then crashed by 59bps to 90.59% in 2017, then crashed by 755bps to 83.04% in 2018, then slumped by 351bps to 79.52% in 2019, then crashed by 523bps to 74.29% in 2020.